Gilead Sciences reported $1.36B in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US $ 3.13B 73M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
ALKERMES ALKS:US 150.38M 5.32M
Alnylam Pharmaceuticals ALNY:US $ 169.98M 15.51M
Amgen AMGN:US $ 1.31B 85M
Biogen BIIB:US $ 572.6M 62.3M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Bluebird Bio BLUE:US $ 36.69M 588K
Bristol Myers Squibb BMY:US $ 1.78B 46M
Coherus Biosciences CHRS:US $ 51.28M 2.52M
Eli Lilly And LLY:US $ 1.63B 67.2M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Glaxosmithkline GSK:US 1.96B 726M
Intercept Pharmaceuticals ICPT:US $ 39.98M 10.02M
Johnson & Johnson JNJ:US $ 6.23B 288M
Merk MRK:US $ 2.42B 118M
Moderna Inc MRNA:US 211M 57M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Ptc Therapeutics PTCT:US $ 79.89M 6.62M
Puma Biotechnology PBYI:US $ 20.58M 174K
Regeneron Pharmaceuticals REGN:US $ 476.3M 26.3M
Sarepta Therapeutics SRPT:US $ 154.32M 82.48M
Teva Pharmaceutical Industries TEVA:US 849M 30M
United Therapeutics UTHR:US $ 141.5M 62.5M
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K
YTE INCY:US $ 253.28M 43.69M